万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生1>>临床神经病学
您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生1>>精神病学
您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生2>>药学
您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生2>>心理学

HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL《人类精神药理学:临床与实验》 (官网投稿)

简介
  • 期刊简称HUM PSYCHOPHARM CLIN
  • 参考译名《人类精神药理学:临床与实验》
  • 核心类别 SCIE(2024版), 目次收录(维普),外文期刊,
  • IF影响因子
  • 自引率3.90%
  • 主要研究方向医学-CLINICAL NEUROLOGY 临床神经病学;PHARMACOLOGY & PHARMACY 药学;PSYCHIATRY 精神病学;PSYCHOLOGY 心理学

主要研究方向:

等待设置主要研究方向
医学-CLINICAL NEUROLOGY 临床神经病学;PHARMACOLOGY & PHARMACY 药学;PSYCHIATRY 精神病学;PSYCHOLOGY 心理学

HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL《人类精神药理学:临床与实验》(双月刊). Human Psychopharmacology: Clinical and Experimental provides a forum for the e...[显示全部]
征稿信息

万维提示:

1、投稿方式:在线投稿

2期刊网址:

https://onlinelibrary.wiley.com/journal/10991077

3投稿网址:https://wiley.atyponrex.com/journal/HUP

4、官网邮箱:编辑邮箱如下。

5期刊刊期:双月刊,逢单月出版

2021年8月13日星期

                                 

 

期刊编辑邮箱【官网信息】

 

EDITOR-IN-CHIEF

Professor David Baldwin

Southampton, UK

E-mail: d.s.baldwin@soton.ac.uk   

 

EDITORIAL MANAGER

Dr Andrew Mayers

Bournemouth, UK

E-mail: amayers@bournemouth.ac.uk

 

ASSOCIATE EDITOR FOR THE FAR EAST

Dr Xirong Li

Jinan, China

E-mail: shandongren82@163.com

 

投稿须知【官网信息】

 

Human Psychopharmacology: Clinical and Experimental

Author Guidelines

Data Protection and Privacy

By submitting a manuscript to, or reviewing for, this publication, your name, email address, institutional affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices.wiley.com/statements/data-protection-policy.html.

Preprint Policy

Human Psychopharmacology: Clinical and Experimental will consider for review articles previously available as preprints. Authors may also post the submitted version of a manuscript to a preprint server at any time. Authors are requested to update any pre-publication versions with a link to the final published article.

1. AIMS & SCOPE

Human Psychopharmacology: Clinical and Experimental (HUP) provides a forum for the evaluation of clinical and experimental research on both new and established psychotropic medicines. Experimental studies of other centrally active drugs, including herbal products, in clinical, social and psychological contexts, as well as clinical/scientific papers on drugs of abuse and drug dependency will also be considered. While the primary purpose of the Journal is to publish the results of clinical research, the results of animal studies relevant to human psychopharmacology are welcome. The following topics are of especial interest to the editors and readers of the Journal:

All aspects of clinical psychopharmacology

Efficacy and safety studies of novel and standard psychotropic drugs

Studies of the adverse effects of psychotropic drugs

Effects of psychotropic drugs on normal physiological processes

Geriatric and paediatric psychopharmacology

Ethical and psychosocial aspects of drug use and misuse

Psychopharmacological aspects of sleep and chronobiology

Neuroimaging and psychoactive drugs

Phytopharmacology and psychoactive substances

Drug treatment of neurological disorders

Mechanisms of action of psychotropic drugs

Ethnopsychopharmacology

Pharmacogenetic aspects of mental illness and drug response

Psychometrics: psychopharmacological methods and experimental design

……

更多详情:

https://onlinelibrary.wiley.com/page/journal/10991077/homepage/forauthors.html


  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭